Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform

NCT04345939 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-10-06

No results posted yet for this study

Summary

Comparison of rapid detection methods of mycobacterial pathogens, GenSeizer v.s. PCR reverse hybridization.

Conditions

  • Mycobacterium Pulmonary Infection

Interventions

DIAGNOSTIC_TEST

Detection method

Different methods for pathogen diagnosis

Sponsors & Collaborators

  • Shanghai Pulmonary Hospital, Shanghai, China

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-28
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04345939 on ClinicalTrials.gov